Herpes simplex virus genes involved in latency in vitro

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Herpes simplex virus (HSV) latency is a critical factor in recurrent viral infections.
• Understanding the molecular mechanisms governing HSV latency and reactivation is essential for developing antiviral strategies.

Purpose of the Study:

• To investigate the role of specific HSV gene products in the establishment and reactivation of viral latency using an in vitro model.
• To define the viral factors necessary for initiating and maintaining latent HSV infections.

Main Methods:

• Utilized temperature-sensitive (ts) and insertion/deletion mutants of HSV type 1 and 2.
• Employed an in vitro model system using human foetal lung fibroblasts.
• Assessed latency establishment and reactivation following superinfection with homologous or heterologous viruses.

Main Results:

• All tested HSV mutants successfully established latency in human foetal lung fibroblasts.
• Mutants tsK and in1411, deficient in immediate early (IE) polypeptide Vmw175, established latency, indicating minimal gene expression is required.
• Mutant dl1403, lacking IE polypeptide Vmw110, established latency efficiently, similar to wild-type HSV.
• Latent HSV type 2 was reactivated by tsK and in1411 but not by dl1403, highlighting Vmw110's role in reactivation.

Conclusions:

• Limited HSV gene expression, specifically the absence of active IE polypeptide Vmw175, is sufficient for the establishment of viral latency.
• The immediate early polypeptide Vmw110 plays a critical role in the reactivation of latent HSV in this in vitro system.
• These findings provide insights into the differential requirements for HSV gene products during latency establishment versus reactivation.